Matarin Capital Management’s Eli Lilly LLY Stock Holding History

Matarin Capital Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-36,395	Closed	-$5.05M	–	211
2020 Q1	$5.05M	Buy	+36,395	New	+$5M	0.78%	41
2015 Q1	–	Sell	-14,889	Closed	-$1.03M	–	188
2014 Q4	$1.03M	Sell	14,889 -759	-5%	-$51.2K	0.45%	109
2014 Q3	$1.01M	Buy	15,648 +2,526	+19%	+$160K	0.47%	106
2014 Q2	$816K	Buy	13,122 +8,606	+191%	+$513K	0.36%	124
2014 Q1	$266K	Buy	+4,516	New	+$252K	0.16%	156
2013 Q4	–	Sell	-5,212	Closed	-$262K	–	144
2013 Q3	$262K	Hold	5,212	–	–	0.22%	143
2013 Q2	$256K	Buy	+5,212	New	+$284K	0.26%	133

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Matarin Capital Management's LLY Position: Q2 2020 in Review

Matarin Capital Management sold out of Eli Lilly (LLY) in Q2 2020, closing a stake of 36,395 shares — an estimated $5.05M sold.

Matarin Capital Management first reported a position in LLY in Q2 2013 and held it in 7 quarters. The position peaked at $5.05M in Q1 2020. 1,764 funds tracked by Wall St. Rank hold LLY as of Q2 2020.

Matarin Capital Management reported no remaining Eli Lilly position as of Q2 2020 after selling out during the quarter.
Matarin Capital Management sold 36,395 Eli Lilly shares in Q2 2020, an estimated $5.05M.
Matarin Capital Management first reported a position in Eli Lilly in Q2 2013 and held it in 7 quarters.
Matarin Capital Management's Eli Lilly position peaked at $5.05M in Q1 2020.
1,764 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2020.

Based on Matarin Capital Management's 13F filing for Q2 2020, filed 6 Aug 2020.